Table 2.
Pregnancy outcomes at 12 months in 83 women allocated to electrocautery strategy and 85 allocated to ovulation induction with recombinant follicle stimulating hormone. Values are numbers (percentages) of women
Treatment regimen | No of women | Pregnant | No of miscarriages* | No of multiple pregnancies | Ongoing pregnancy | No of premature deliveries | Live births |
---|---|---|---|---|---|---|---|
Electrocautery strategy: | |||||||
Electrocautery | 83 (100) | 31 (37) | 3 | — | 28 (34) | — | 28 (34) |
Electrocautery and clomiphene citrate | 45 (54) | 14 (31) | 1 | — | 13 (29) | — | 13 (29) |
Electrocautery, clomiphene citrate, and recombinant follicle stimulating hormone | 23 (28) | 18 (78) | 3† | 1 | 15 (65) | 3 | 12 (52) |
Electrocautery strategy: total | 83 | 63 (76) | 7 | 1 | 56 (67) | 3 | 53 (64) |
Recombinant follicle stimulating hormone | 85 | 64 (75) | 7 | 9 | 57 (67) | 6 | 51 (60) |
<12 weeks.
Includes one ectopic pregnancy.